Cross Country Healthcare (NASDAQ:CCRN) Earns Market Perform Rating from Barrington Research

Barrington Research reissued their market perform rating on shares of Cross Country Healthcare (NASDAQ:CCRN - Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. They currently have a $18.61 price objective on the business services provider's stock. Barrington Research also issued estimates for Cross Country Healthcare's Q2 2025 earnings at $0.04 EPS, Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.09 EPS and FY2025 earnings at $0.26 EPS.

CCRN has been the topic of several other research reports. UBS Group dropped their target price on Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating on the stock in a research report on Tuesday, May 13th. Wall Street Zen assumed coverage on Cross Country Healthcare in a research report on Thursday, May 15th. They set a "hold" rating on the stock. Seven equities research analysts have rated the stock with a hold rating, According to data from MarketBeat, Cross Country Healthcare presently has a consensus rating of "Hold" and a consensus target price of $17.93.

Cross Country Healthcare Trading Down 1.5%

Shares of Cross Country Healthcare stock traded down $0.22 on Tuesday, hitting $14.03. The stock had a trading volume of 1,074,278 shares, compared to its average volume of 580,101. Cross Country Healthcare has a 52-week low of $9.58 and a 52-week high of $18.50. The stock has a market cap of $459.90 million, a price-to-earnings ratio of -26.47, a P/E/G ratio of 4.37 and a beta of 0.37. The company's 50 day moving average price is $13.69 and its 200 day moving average price is $15.92.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. Cross Country Healthcare had a positive return on equity of 2.56% and a negative net margin of 1.41%. Cross Country Healthcare's revenue was down 22.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.19 EPS. Analysts predict that Cross Country Healthcare will post 0.53 EPS for the current fiscal year.

Hedge Funds Weigh In On Cross Country Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in CCRN. Quadrant Capital Group LLC purchased a new stake in shares of Cross Country Healthcare during the 4th quarter worth approximately $25,000. Plato Investment Management Ltd purchased a new stake in shares of Cross Country Healthcare during the 4th quarter worth approximately $46,000. Longfellow Investment Management Co. LLC purchased a new stake in shares of Cross Country Healthcare during the 1st quarter worth approximately $59,000. AlphaQuest LLC boosted its stake in shares of Cross Country Healthcare by 324.6% during the 1st quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider's stock worth $124,000 after acquiring an additional 6,343 shares in the last quarter. Finally, Mint Tower Capital Management B.V. purchased a new stake in shares of Cross Country Healthcare during the 4th quarter worth approximately $182,000. Institutional investors and hedge funds own 96.03% of the company's stock.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.